踝关节病的人工踝关节置换

[目的]探讨人工踝关节置换治疗踝关节病的疗效。[方法]对1999~2004年1月的18例患者包括骨性踝关节炎6例,创伤性踝关节炎9例,局限性距骨缺血坏死2例,踝关节融合后1例,均采用L ink STAR假体3构件套进行人工踝关节置换。18例中,男13例,女5例;平均年龄47.7岁(38~67)。[结果]随访平均3 a 9个月(1~5 a)。按Kofoed评价系统观察疗效,优(85~100)16例,良(75~84)2例,无可(70~74)和差(<70)。患足背屈平均8°(范围6°~12°),跖屈12°(范围8°~16°),背屈和跖屈平均16°(11°~23°)。并发症有切口皮缘坏死2例,无足内、外翻和影像学松动。[结论]人工踝关节置换是治疗和替代踝关节多种疾患疼痛和需要融合的良好方法。     

成人正常股骨解剖测量及其在膝关节置换的临床意义

[目的]为膝关节置换准确截骨和获得良好的下肢力线，对中原地区成人股骨干进行相关测量。[方法]（1）选取47根成人正常股骨标本，拍摄正、侧位数码照片，进行定点、划线、测量五角。（2）实体上确定股骨髓内定位杆进针点的位置：[结果]（1）各角度值反映了股骨远端在冠状位和矢状位的解剖形态。（2）进针点与股骨滑车中心水平距离平均为6．21mm，与后交叉韧带止点前缘距离平均为6．70mm。[结论]（1）股骨远端1／3段与股骨近端1／3段向外侧、前侧成角，且前倾角度大于外翻角度。所以股骨远端在决定股骨髓内定位杆的位置时，冠状面上的力线对位和矢状面上的对位均很重要。（2）全膝关节置换术中确定进针点可参考股骨滑车中心和股骨髁后交叉韧带止点的位置。     

胫骨高位截骨术治疗膝内翻伴膝外摆步态的疗效与不足

[目的]探讨外侧闭合胫骨高位截骨术治疗膝内翻伴膝外摆步态患者的临床效果及相关的影响因素。[方法]随访2000~2004年因膝内翻伴膝外摆步态于本院行胫骨高位截骨手术的患者19例,年龄47~54岁,随访时间6个月~4 a。术前及术后X线片测量股骨-胫骨角、胫骨平台后倾角和腓骨小头高度,HSS膝关节功能评分,关节后外侧稳定性测试,术后患者以五点问卷法评价术后关节稳定性的改善情况。[结果]股骨-胫骨角术前184.5°~197°,术后167°~176°;腓骨小头高度术前7.73~18.5 mm,术后-3.5~10.7 mm;胫骨后倾角术前2°~17°,术后-4°~13°;HSS评分术前48~68分,术后60~91分(P=0.00)。后外侧的稳定性测量术前Ⅰ度损伤16例,Ⅱ度损伤3例。术后Ⅰ度损伤9例,Ⅱ度损伤10例(P<0.05)。术后患者关节稳定性的问卷4例明显提高,9例有提高,6例与术前相同。[结论]外侧闭合胫骨高位截骨治疗膝内翻合并膝外摆的近期效果良好,远期效果可能受到膝外摆步态、胫骨后倾角和腓骨小头高度改变的影响。     

人工全膝关节表面置换治疗骨关节疾病52例

目的探讨人工全膝关节表面置换(TKA)治疗骨关节病的疗效。方法对52例56个膝关节行TKA。结果52例均获随访,时间10~62个月,平均48.4个月。患者术后在疼痛、功能方面改善明显;膝关节评分应用HSS评分系统,由术前平均46.2分提高到86.3分。术后52个膝关节平均活动度为108,°53个膝关节术后膝关节力线正常,3膝残留6°~8°内翻。手术优良率90.4%。结论TKA对治疗严重膝关节炎效果满意,术中精确的截骨及正确的软组织松解以获得软组织平衡和注重术中髌骨轨迹的纠正是手术成功的关键。     

人工髋关节置换术早期并发症临床分析

目的探讨人工髋关节置换术早期并发症的防治方法。方法分析21例人工髋关节置换术患者发生早期并发症的原因并提出防治措施。结果21例中假体柄周围骨折7例,术后早期脱位5例,下肢深静脉栓塞8例,下肢不等长1例。经治疗后效果满意。结论术中正确的手术操作、术后早期进行功能康复能有效地防止或减少早期并发症的发生。     

寰枢关节旋转运动CT扫描的临床意义

目的了解不同旋转状态下CT扫描寰枢关节的影像学变化,探讨CT对寰枢关节旋转固定的诊断价值。方法分别对正常组30例、寰枢关节旋转固定患者组16例、新鲜尸体标本组5例行头部功能位CT扫描,测量并比较各组的寰齿前间隙、寰齿侧间隙及寰枢椎相对旋转角的变化。结合标本解剖观察寰枢关节不同旋转状态在SSD法重建图像上的表现。结果不同旋转状态下CT扫描寰枢关节的影像表现变化较大。旋转前后正常组与寰枢关节旋转固定患者组相比:寰齿前间隙及寰枢关节相对旋转范围变化差异有显著性(P<0·01),寰齿侧间隙的变化差异无显著性(P>0·05),寰枢关节不同旋转状态下在SSD法重建图像上表现与标本解剖观察基本一致。结论静态CT扫描不能准确诊断Ⅰ型寰枢关节旋转固定,功能位CT扫描能够准确诊断寰枢关节旋转固定。     

Validation of 5 prediction models for acute kidney injury and its outcome after cardiac surgery procedures in Chinese patients

ObjectiveTo assess the clinical usefulness and value of the 5 models for the prediction of acute kidney injury (AKI), severe AKI which renal replacement treatment was needed (RRT-AKI) and death after cardiac surgery procedures in Chinese patients. Methods One thousand and sixty - seven patients who underwent cardiac surgery procedures in the department of cardiac surgery in the Zhongshan Hospital, Fudan University between May 2010 and January 2011 were involved in this research. The predicting value for AKI (AKICS), RRT-AKI (Cleveland, SRI and Mehta score) and death (EURO score) after cardiac surgery procedures was evaluated by Hosmer-Lemeshow goodness-of-fit test for the calibration and area under receiver operation characteristic curve (AUROC) for the discrimination. ResultsThe incidence of AKI was 20.34%(217/1067), and 63.13% of their renal function recovered completely. The incidence of RRT-AKI was 3.56%(38/1067) and the mortality of AKI and RRT - AKI was 9.68%(21/217) and 44.73%(17/38) respectively. The total mortality was 3.28%（35/1067）. The discrimination and calibration for the prediction of AKI of AKICS were low. For the prediction of RRT-AKI, the discrimination and calibration of Cleveland score were high enough, but the predicated value was lower than the real value (1.70% vs 3.86%). The discrimination of Mehta score and the calibration of SRI were low. The discrimination and calibration for the prediction of death of EURO score was low. ConclusionAccording to the 2012 KDIGO AKI definition, none of the 5 models above is good at predicting AKI after cardiac surgery procedures. Cleveland score has been validated to have a proper impact on predicting RRT-AKI after cardiac surgery procedures, but the predicting value is still in doubt. EURO score has been validated to have an inaccurate predicting value for death after cardiac surgery procedures.     

Study on malignancy of end-stage aristolochic acid nephropathy patients in Wenzhou area

Objective To investigate the features of malignancy in end-stage aristolochic acid nephropathy (AAN) patients undergoing renal replacement therapy in the First Affiliated Hospital of Wenhou Medical University. Methods One hundred and two patients diagnosed as end-stage AAN during 2004 to 2013 were enrolled in the study, and separately udergoing hemodialysis, peritoneal dialysis and renal transplantation, to study the features of the malignancy and its risk factors. Results (1) There were totally 42 AAN patients suffering from malignancy, and 39 of them had urinary cancer. Eight cases of urinary cancer had metastasis, and 11 cases of bladder cancer had repeated recurrences. Patients suffering from malignancy had an increased mortality compared to patients without malignancy(13/42 vs 7/60, P=0.022). (2) Thirteenmalignacy cases were diagnosed before the end-stage of AAN, the rest cases appeared in 1-13 years[(4.62±3.31) years] after renal replacement. (3) A further logistic regression analysis of the 29 maligancy patients after renal replacement showed that, the dose of aristolochic acid (counted by Mutong) was the only risk factor of malignancy (P=0.091), compared with the dose of Mutong less than 60 g, the patients with an accumulated dose of Mutong more than 200 g had a 4.26 folds（95%CI 1.02, 17.83）higher risk of malignancy. There was no statistic difference of the malignancy risk among different renal replacement therapies, which however might influence the pathogenic sites of the urinary cancer. The simple bladder cancer was the most common malignancy among the hemodialysis patients (72.72%), and the upper urinary tract cancer among the peritoneal dialysis patients (66.67%), while the complex of both were dominant among the renal transplantation patients(40.00%). Conclusions Among the end-stage of AAN patients undergoing renal replacement therapy in Wenzhou area, the incidence of urinary cancer is high, with a character of complex, multiple and repeated recurrences. The occurence of malignancy seems to be separated from the renal function, but turns out obviously dose-dependent. There was no statisticaldifference of cancer risk among hemodialysis, peritoneal dialysis, and renal transplantation, which may induce different pathogenic sites of the urinary cancer.     

Osseointegrated wrist-joint prostheses: A 15-year follow-up with focus on bony fixation

Five patients with rheumatoid arthritis or osteoarthrosis of the wrist joint were followed up for 15 (14–17) years after wrist-joint arthroplasty with semiconstrained artificial joint mechanisms that had been anchored to bone using the osseointegration principle. They were fixed by one titanium screw introduced into the radius, and two or more titanium screws introduced distally into the metacarpal bones. In four cases a screw was also introduced into the ulna thereby constituting one component in a distal radio-ulnar (DRU) joint mechanism. The titanium screw introduced into the radius and the distal metacarpal screws osseointegrated in all cases. In three cases the mechanism of the wrist joint or parts of it were replaced with new components that could be attached to the screws that were already osseointegrated. We conclude that wrist joint prostheses can be anchored to the surrounding bone using osseointegration and that they remain fixed for at least 15 years. The principle allows replacement of the joint mechanism, if needed, with maintenance of the osseointegrated anchoring elements.     

Belgian and European Experience with the European Homograft Bank (EHB) Cryopreserved Allograft Valves.-Assessment of a 20 Year Activity

European Homograft Bank (EHB) has been selecting, preparing, storing and distributing the cryopreserved allograft valves in Belgium and some other European Countries since 1989. It was established in 1988 by a pathologist and the cardiac and vascular surgeons from Belgian and other European centres as an inter-university, international nonprofit association. Due to its neutral behavior and very high quality criteria, European Homograft Bank became one of the prominent heart valve banks in Europe and wider. It collaborates with the transplant coordination in donor selection as well as with the huge network of the implanting surgeons in Belgium and other European Countries. The EHB responsible discusses with the implanting surgeon the allograft selection on basis of the indication and the patients state of emergency.

A total of 8.911 donor heart valves have been evaluated in EHB during the last 20 years. After selection, 5.258 allograft valves (1.996 aortic, 3.189 pulmonary and 73 mitral) were cryopreserved and stored in vapors of liquid nitrogen between 6 weeks and 5 years. A total of 4.516 allograft valves (1.391 aortic, 2.620 pulmonary and 48 mitral) were implanted in the left or right ventricular outflow tract for replacement of the diseased aortic or pulmonary valve and for mitral or tricuspid valve replacement or repair. In 1.380 cases the allograft valves were used for right ventricular outflow tract reconstruction as part of the Ross-procedure, whereas in 668 cases the allograft valve served for replacement of the aortic valve for endocarditis. The most important indications for use of cryopreserved allograft valves were: important cardiac and valve malformation in children, female patients of child-bearing age with diseased cardiac valves, cases with contra-indication for anti-coagulation and the patients with severe endocarditis with septal or annular abscesses. Although the number of the donation increased by year, the available allograft valves in stock are still insufficient to respond to all the surgeons’ request for different indications.